Skip to main content
padlock icon - secure page this page is secure

Effect of Therapeutic Hypothermia on Drug Metabolism

Buy Article:

$17.00 + tax (Refund Policy)

THERAPEUTIC HYPOTHERMIA is increasingly used for neonates older than 36-weeks gestation who meet specific criteria following an apparent, acute perinatal hypoxic or ischmeic event. In their systematic review of eight randomized controlled trial of therapeutic hypothermia, which included 638 newborn infants, Jacobs and associates concluded that therapeutic hypothermia reduces death or disability in term newborns who have suffered a hypoxic episode around the time of birth. With increased application of therapeutic hypothermia, it is important to understand the impact of this therapy on other therapies used concomitantly. In a recent review of the literature, Tortorici and colleagues found that the therapeutic hypothermia has an effect on drug metabolism, elimination, and response. However, because there maybe a different response depending on the class of the drug, generalizations about adjusting dosing cannot be made. This column will review aspects of drug metabolism and relevant studies of the metabolism specific drugs in human neonates treated with hypothermia. Because few studies have addressed the effects of hypothermia on drug metabolism in neonates, this area is ripe for research.

No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Research Article

Publication date: January 1, 2012

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more